Skip to content

    Research Use Only

    This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.

    🔬 100K+ researchers trust BodyHackGuide — Join r/BodyHackGuide
    Metabolic & Weight LossFDA Approved

    Semaglutide Dosage Guide: Protocols, Calculator & Safety

    Everything you need to know about Semaglutide dosing — protocols, safety, and where to buy.

    Dose Range

    Diabetes (Ozempic): 250-1000 mcg weekly; Weight management (Wegovy): 2400 mcg weekly (after 16-week titration); Oral (Rybelsus): 3-14 mg daily

    Frequency

    Once weekly subcutaneous injection

    Cycle Length

    Ongoing; dose escalation over 16–20 weeks to maintenance dose

    Half-Life

    ~7 days (168 hours), enabled by C18 fatty diacid albumin-binding modification

    Administration Routes

    Subcutaneous (weekly)Oral (daily)

    Quick Reconstitution Calculator

    Calculate syringe units instantly

    Syringe Draw

    10.0 units

    2500 mcg/ml · 0.100 ml draw

    Full Tool

    Dosing Protocols

    Beginner

    0.25 mg subcutaneous once weekly for 4 weeks (dose escalation start).

    Standard

    Escalate: 0.25mg x4 weeks → 0.5mg x4 weeks → 1mg x4 weeks → 1.7mg x4 weeks.

    Advanced

    Full escalation to 2.4 mg weekly (Wegovy® dose) over 16–20 weeks. Maintain at highest tolerated dose.

    Weight-Based Dosing

    Not weight-based. Fixed dose escalation schedule per FDA labeling.

    Commonly Stacked With

    Clinically studied in combination with cagrilintide (CagriSema). Not typically stacked in research community. Avoid combining with other GLP-1 agonists.

    Related Compounds — Deeper Research Paths — Semaglutide is the reference GLP-1 mono-agonist. Newer-generation alternatives with higher weight-loss efficacy: Tirzepatide (dual GLP-1/GIP, ~22.5% loss in SURMOUNT-1), Retatrutide (triple GLP-1/GIP/glucagon, ~24% at Phase 2), and Mazdutide (GLP-1/glucagon). Adjuncts that amplify outcomes: Cagrilintide (amylin analog stacked as CagriSema), AOD-9604 (HGH fragment for abdominal-fat preservation of lean mass), Tesamorelin (visceral-fat specific GHRH), and Tesofensine (triple monoamine reuptake inhibitor). Oral alternatives: Orforglipron (non-peptide GLP-1). Insulin-sensitizing context: Berberine, Metformin, and NMN.

    Side Effects & Safety

    Nausea (especially at initiation — dose-dependent), vomiting, diarrhea, constipation, abdominal pain, decreased appetite (therapeutic effect), headache, fatigue, dizziness. Rare: pancreatitis, gallbladder issues, thyroid C-cell tumors (rodent studies). Injection site reactions with subcutaneous formulation.

    Contraindications

    Personal or family history of medullary thyroid carcinoma (MTC). Multiple endocrine neoplasia syndrome type 2 (MEN 2). History of pancreatitis. Severe gastrointestinal disease. Type 1 diabetes. Pregnancy or breastfeeding. Eating disorders (may exacerbate restriction).

    Check interactions with the Interaction Checker →

    Additional Notes

    FDA-approved as Ozempic® (diabetes, max 2mg) and Wegovy® (obesity, max 2.4mg). Slow dose escalation is CRITICAL to minimize GI side effects. Inject same day each week. Can change injection day if needed (minimum 48 hours between doses). Store refrigerated before first use.

    Where to Buy Semaglutide

    Compare 13 listings across 7 vendors — from $39.00

    Frequently Asked Questions

    What is the recommended Semaglutide dosage?

    The typical dose range for Semaglutide is Diabetes (Ozempic): 250-1000 mcg weekly; Weight management (Wegovy): 2400 mcg weekly (after 16-week titration); Oral (Rybelsus): 3-14 mg daily. It is usually administered Once weekly subcutaneous injection. Always start with the lowest effective dose.

    How often should I take Semaglutide?

    Once weekly subcutaneous injection

    Does Semaglutide need to be cycled?

    Yes, typical cycle length is Ongoing; dose escalation over 16–20 weeks to maintenance dose.

    What are Semaglutide side effects?

    Nausea (especially at initiation — dose-dependent), vomiting, diarrhea, constipation, abdominal pain, decreased appetite (therapeutic effect), headache, fatigue, dizziness. Rare: pancreatitis, gallbladder issues, thyroid C-cell tumors (rodent studies). Injection site reactions with subcutaneous formulation.

    Where can I buy Semaglutide?

    Compare 13 listings from 7 vendors on our price comparison page — starting from $39.00.

    Free 2026 Peptide Cheat Sheet — 50 pages, PDF

    Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.

    Download Free